Contact Us

Global Artificial Intelligence AI In Omics Studies Share 2025, Forecast To 2034

11 Mar, 2025

What Has Been the Progress and Growth of the Artificial Intelligence AI In Omics Studies Market in Recent Years?

The artificial intelligence ai in omics studies market has seen considerable growth due to a variety of factors.
• The market size for artificial intelligence (AI) applied in omics studies has seen significant growth over the past few years. The market, which is projected to expand from $0.91 billion in 2024 to $1.23 billion in 2025, is set to experience a compound annual growth rate (CAGR) of 35.4%.
Factors such as wider adoption of artificial intelligence, an uptick in research activities, the increasing occurrence of chronic diseases, the escalation of healthcare expenses, and its growing application in cancer treatment have all contributed to this historic growth phase.

What Can Be Expected from the Artificial Intelligence AI In Omics Studies Market By 2029?

The artificial intelligence ai in omics studies market is expected to maintain its strong growth trajectory in upcoming years.
• The market size of artificial intelligence (AI) in omics studies is predicted to witness substantial growth in the forthcoming years, escalating to $4.11 billion in 2029 with a compound annual growth rate (CAGR) of 35.2%.
This anticipated growth in the forecast period is a result of the increasing demand for individualized medicine, the rising need for assay assistance, the expansion of genetic and genomic data, escalated investment in genomic research, and growth in disposable income. Prevailing trends during the forecast period encompass improvement in artificial intelligence technologies, the progress of high-throughput methodologies, the techniques of deep learning, the automation of data interpretation in omics studies, and predictive analytics.

Which Key Drivers Are Propelling The Artificial Intelligence AI In Omics Studies Market's Growth?

The growth of artificial intelligence in omics studies market is predicted to be fueled by the rising requirement for personalized medicine. Personalized medicine, which modifies healthcare to align with the unique characteristics of each individual, is increasing due to advancements in genomic medicine, enhanced diagnostic tools, and a data-based approach to healthcare. It maximizes therapeutic efficiency and reduces negative effects, bearing in mind the patient's genetic, environmental, and lifestyle factors. AI in omics studies contributes to personalized medicine by allowing deeper understanding into the molecular aspects of diseases, refining the precision of treatments, and ensuring better patient results. In October 2022, as reported by the US-based Personalized Medicine Coalition, about 34% of all newly approved treatments were for 12 new personalized medicines, representing a significant rise from previous years. Hence, the growing need for personalized medicine is boosting the growth of artificial intelligence in omics studies.

How Is The Artificial Intelligence AI In Omics Studies Market segmented?

The artificial intelligence (AI) in omics studies market covered in this report is segmented –
1) By Offering: Software, Services
2) By Technology Platform: Sequencing, Epigenomics, Proteomics, Metabolomics, Other Technologies
3) By Application: Oncology, Infectious Diseases, Neurology, Cardiovascular Diseases, Immunology, Other Applications
4) By End-User: Academic And Research Institutes, Biopharmaceutical Company, Other End-Users Subsegments:
1) By Software: AI-Powered Data Analytics Software, Omics Data Integration Software, Machine Learning Platforms for Genomics, AI-Based Protein Structure Prediction Software, AI-Based Drug Discovery Software, AI for Metabolomics Analysis Tools, AI-Driven Genome Sequencing Software, Bioinformatics Software for Multi-Omics Data
2) By Services: AI-Based Data Analysis Services, Consulting Services for AI in Omics, AI Model Development and Customization Services, Omics Data Management and Interpretation Services, AI-Driven Drug Discovery and Development Services, Cloud-Based Omics Data Storage and Processing Services, AI-Based Omics Training and Support Services

Pre-Book The Artificial Intelligence AI In Omics Studies Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:

What New Trends Are Influencing The Artificial Intelligence AI In Omics Studies Market?

Major firms in the artificial intelligence for omics studies sector are focusing on the creation of cutting-edge solutions, such as cloud-based models that utilize data federation principles to improve data cooperation and exchange among various research bodies. This permits an effortless combination and examination of significant omics data from diverse sources, maintaining data confidentiality and security. The cloud-based systems assimilate various types of omics data such as genomics, proteomics, and metabolomics and use machine learning methods to analyze the information and produce findings. For example, DNAstack, a Canadian biotech firm, introduced Omics AI in September 2023, a pioneering software collection created to expedite omics research. The exclusive attributes of Omics AI incorporate its capacity to manage vast datasets, offer real-time analytics, and facilitate global collaboration amongst researchers. Even though this innovation boosts the effectiveness of omics studies, it also brings up discussions surrounding the security of data and the requirement of a strong cybersecurity framework to safeguard delicate genetic data.

Who Are the Key Players In The Artificial Intelligence AI In Omics Studies Market?

Major companies operating in the artificial intelligence in omics studies market are:
• Amazon.com Inc.
• Hitachi Ltd.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• Siemens Healthineers AG
• General Electric Company
• Agilent Technologies Inc.
• Koninklijke Philips N.V.
• Dassault Systemes SA
• Illumina Inc.
• Fujifilm Holdings Corporation
• Shimadzu Corporation
• Waters Corporation
• Bio-Rad Laboratories Inc.
• Canon Medical Systems Corporation
• Bruker Corporation
• Qiagen N.V.
• BGI Genomics Co Ltd.
• Takara Bio Inc.
• Elekta AB

What Is The Most Dominant Region In The Artificial Intelligence AI In Omics Studies Market?

North America was the largest region in the artificial intelligence in omics studies market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in omics studies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.